Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Evaluations of Ketohexokinase Isoforms in Endometrial Cancer

NCT03931265 is registered in ClinicalTrials.gov with Far Eastern Memorial Hospital as lead sponsor.

NCT NCT03931265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03931265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Evaluations of Ketohexokinase Isoforms in Endometrial Cancer
Lead sponsor
Far Eastern Memorial Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 11, 2019
Completion date
December 31, 2024
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer